Surface electromyography as a non-invasive method for detecting stress-induced changes in gastrointestinal motility in pigs Authors: Orsolya Csötönyi, Gabriella Béres, Ágnes Baráth, László Sarkadi, Zsuzsanna Szőke, Zsófia Molnár, Patrik Plank, Veronika Halas, Ewa Tomaszewska, Ewa Tomaszewska, Ewa Tomaszewska Published: 2026 ABSTRACT Surface electromyography of the gastrointestinal tract is a non-invasive method for monitoring smooth muscle myoelectrical activity and provides an integrated assessment of gastrointestinal motility. Although prolonged or marked stress is known to impair digestive efficiency in livestock, partly via cortisol-mediated modulation of gastrointestinal smooth muscle activity, it remains unclear whether a single mild stressor can induce detectable alterations in motility. Therefore, this study aimed to determine whether a single mild, experimentally induced stressor alters gastrointestinal motility in pigs and whether surface electromyographic measurements are sufficiently sensitive to detect these changes. Four growing pigs were examined using a within-individual experimental design on a baseline control day and on a treatment day involving intravenous administration of adrenocorticotropic hormone (10 micrograms per kilogram body weight) to induce a mild stress response. Gastrointestinal smooth muscle electrical activity was recorded non-invasively using surface electromyography, and repeated blood samples were collected to determine serum cortisol concentrations over time. Adrenocorticotropic hormone administration produced a clear, time-dependent increase in serum cortisol concentrations, confirming the effectiveness of the experimental stress model. This endocrine response was accompanied by a significant reduction in small intestinal smooth muscle activity, whereas gastric and large intestinal activity showed no statistically significant changes, although a consistent tendency toward reduced motility was observed under stress. These findings indicate that small intestinal myoelectrical activity is particularly sensitive to mild endocrine stress and demonstrate that non-invasive surface electromyography can detect stress-related alterations in gastrointestinal function. This approach may provide a useful tool for investigating stress physiology and monitoring digestive function in livestock. Introduction Electromyography (EMG) refers collectively to methods used to measure muscle activity, while the non-invasive measurement of muscle function is termed surface electromyography (sEMG). Different forms of EMG allow the investigation of both skeletal and smooth muscle function. A specialized variant, smooth muscle electromyography of the gastrointestinal tract (SMEMG), is used to monitor the myoelectrical activity of various segments of the digestive system. This method provides an integrated overview of gastrointestinal motility under both physiological and altered conditions and can be applied to assess gastric, small intestinal, and large intestinal smooth muscle activity [3]. The physiological basis of electromyographic measurements is that when a smooth muscle cell membrane receives a stimulus, the voltage difference between the intracellular and extracellular compartments – the resting membrane potential – changes transiently. The stimulus increases membrane permeability to sodium ions (Na⁺), which enter the cell in large quantities. As a result, the intracellular membrane surface becomes temporarily positive while the extracellular surface becomes negative, a process known as depolarization. Depolarization triggers electrical activation that leads to the generation of an action potential. Shortly afterward, the membrane potential returns to its resting state (repolarization). The electrical activation promotes substantial intracellular release of calcium ions (Ca2+), which, after a brief delay, induces smooth muscle fiber contraction [1]. The smooth muscle tissues of the gastrointestinal organs contain intrinsic pacemaker cells known as interstitial cells of Cajal. These cells play a key role in generating and propagating the electrical signals that underlie smooth muscle contractions. They produce characteristic slow-wave electrical impulses, which can be detected through the electrical and mechanical activity of smooth muscle cells, and their frequency can be quantified [2]. Based on these frequency domains – and with appropriate signal-processing techniques – smooth muscle activity can be distinguished from signals originating from skeletal muscle. Reliable software-based analysis therefore requires prior knowledge of the characteristic frequency ranges of each intestinal segment. Currently, sEMG has not become an established method for analyzing gastrointestinal motility in livestock species, including pigs. Only a very limited number of studies have applied SMEMG in pigs [3,4], and none have examined gastrointestinal myoelectrical activity under stress conditions. Although the stress-induced reduction of gastrointestinal motility has been documented across several species [5–7], the available literature indicates that these effects have not yet been supported by quantitative evidence using non-invasive monitoring approaches. Furthermore, a fully standardized protocol for measurements in awake, non-anesthetized large animals has not yet been established. In rats, characteristic cycles-per-minute (CPM, defined as the number of complete myoelectrical contraction cycles recorded per minute) ranges for distinct gastrointestinal segments were defined under controlled experimental conditions in which the organs were examined separately to avoid potential cross-interference [8]. In pigs, Nagy et al. demonstrated the applicability of rat-derived CPM ranges [3], and Salimi-Jazi et al. [4] reported segmental CPM values obtained in vivo from awake animals using simultaneous internal and external recordings [4]. However, in vivo measurements inherently allow physiological interactions between adjacent gastrointestinal segments, which may influence segment-specific myoelectric patterns. Therefore, until more extensively validated and harmonized porcine reference data become available, the use of CPM ranges derived from experimentally isolated segments may represent a pragmatic and methodologically consistent approach in pigs. Importantly, while the establishment of universally accepted reference CPM ranges in pigs remains under refinement, the methodological feasibility of in vivo measurements has been convincingly demonstrated. Recently, Salimi-Jazi et al. compared the measurements obtained from surgically implanted internal electrodes with those recorded using surface electrodes in the gastrointestinal organs (stomach, small intestine, and large intestine) of Yucatan minipigs [4]. The results demonstrated a high correlation between the two methods, supporting the potential applicability of non-invasive measurements. They also reported that non-invasive, continuous monitoring of gastrointestinal myoelectrical activity over several days can serve as a useful tool for diagnosing motility disorders. This implies that stress-induced alterations in gastrointestinal activity may also be detectable using such measurement techniques. The aim of the study was to determine whether a single mild, experimentally induced stressor alters gastrointestinal motility in pigs and whether surface electromyographic measurements are sufficiently sensitive to detect these changes. Materials and methods The animal experiment has been approved by the Animal Welfare Committee and Scientific Ethics Council for Animal Experiments (Somogy County District Office of Kaposvár Food Chain Safety and Animal Health Unit; Ethical approval number: SO/31/00881–2/2023 (KA-3926)). At the end of the study, the animals were not euthanized. Following completion of the experimental procedures, all pigs underwent veterinary examination, and after confirmation of their healthy clinical status, they were returned to the food production chain in accordance with the approved animal welfare protocol. The experiment was conducted in December 2023 at the Hungarian University of Agriculture and Life Sciences, Department of Farm Animal Nutrition. Four Topigs × Duroc growing barrows (25.9 ± 0,62 kg body weight) were housed individually in concrete-floored pens without bedding and were fed twice daily (08:00 and 15:00 h) with ad libitum access to drinking water. Preparation and habituation of the animals Because the study focused on the effects of stress induction within a self-control design, animals underwent a one-month habituation period to ensure tolerance of human presence, handling, and wearing a vest, which held the wires and the Holter device in position for sEMG measurements (Fig 1.). One of the experimental pigs with vest and Holter device. To enable repeated blood sampling (16 samples/day) and intravenous ACTH administration while minimizing procedure-related stress, permanent jugular venous catheters were surgically implanted 4 days before the experiment. General anesthesia was induced with intramuscular Zoletil® 50 (4 mg/kg), followed by inhalational anesthesia with isoflurane in oxygen. After induction, the animals were intubated, and anesthesia was maintained with 2% isoflurane in oxygen. The catheter was inserted into the jugular vein through a small skin incision and secured with sutures. Local analgesia was provided by infiltration and topical application of 1% lidocaine prior to intubation and venous catheterization. Physiological parameters, including electrocardiogram (ECG), oxygen saturation, and body temperature, were continuously monitored throughout surgery. Following surgery, the incision site and sutures were inspected daily and cleaned as needed throughout the experimental period. Catheter patency was maintained by daily flushing with heparinized saline. All procedures were performed by appropriately trained personnel in accordance with the approved animal welfare protocol. Study design and stress induction Each pig was evaluated on two consecutive days (Fig 2.): a control day without stress induction, and a treatment day during which stress was elicited via intravenous administration of ACTH (Synacthen; 0.25 mg/mL) through permanent venous catheter at a dose of 10 µg/kg body weight, representing a mild, short-term, cortisol-mediated stress stimulus. Study design and sampling schedule on experimental days. Blood sampling and serum cortisol measurements At each sampling time point (Fig 2.), 4 mL of blood was collected into serum tubes, centrifuged at 2,500 × g for 15 min at 4 °C, and the obtained serum was stored at −20 °C until analysis. Serum cortisol concentrations were quantified using a quantitative enzyme-linked immunosorbent assay (ELISA) kit (Cortisol ELISA, Gold Standard Diagnostics, Product No.: DNOV001, Lot: CORT-6028A) following the manufacturer’s protocol. No extraction or dilution steps were necessary prior to the analysis. Briefly, 20 µL of standards and samples were dispensed into the wells, accompanied by 200 µL of enzyme conjugate, and incubated for 1 h at 37 °C. Following this, the wells were washed with 300 µL of wash solution per well and 100 µL of TMB substrate was added. The plates were then incubated for 15 min at room temperature in the dark. The enzymatic reaction was terminated by adding 100 µL of stop solution, and the optical density was measured at 450 nm using a Multiscan ELISA reader (Waltham, MA, USA). Surface electromyographic measurements and data analysis SMEMG data were collected using a Holter device (DR4CH01, MSB-Met Kft., Hungary) connected to two disposable, self-adhesive foam surface electrodes (3M™ Red Dot™, 4 × 3.3 cm; 3M, St. Paul, USA) placed after shaving the area and cleaning the skin with 96% (v/v) ethanol. One electrode was positioned on the left side near the heart, right behind the front left leg. The other electrode on the right side was placed on the fold of skin connecting the pig’s thigh and lower abdomen (Fig 3.). Measurements were recorded for 9 hours (Fig 2.), of which 8 hours were analyzed using EasyChart software. The recording was segmented into 30-minute intervals. Two predefined analysis windows were applied: from the time of ACTH administration to 2 hours post-injection, and from 30 minutes before feeding to 90 minutes after feeding (in the afternoon). Feeding occurred 4 hours after ACTH administration. Electrode placement during EMG measurements. The electrical signals were recorded using the Holter recording system, which included built-in hardware signal conditioning. The gastrointestinal electrical activity channels were amplified with a gain of ×2000 and recorded with a bandwidth of 0.01–1 Hz. Signals were digitized at a sampling rate of 1000 samples/s (1000 Hz). No additional preprocessing or artifact-reduction procedures were applied by the Holter system prior to signal analysis. Organ-specific signal separation was performed using predefined frequency filters implemented in the EasyChart software (Fig 4). The applied frequency ranges were given in CPM (cycle-per-minute) defined as the number of complete myoelectrical contraction cycles recorded per minute and set 3–5 CPM for the stomach, 10–20 CPM for the small intestine and 1–3 CPM for the large intestine. The frequency unit CPM is conventionally used for the characterization of gastrointestinal myoelectrical activity; for comparison with SI frequency units, CPM values can be converted to Hertz (Hz; 1 Hz = 60 cycles/min). Example of raw gastrointestinal myoelectrical signals from the stomach, small intestine, and large intestine displayed in the software before FFT analysis; time is shown on the x-axis. Following frequency filtering, Fast Fourier Transform (FFT) analysis was performed within each predefined organ-specific frequency range, and the Power Spectrum maximum (PSmax) value was determined for each 30-minute interval. PSmax was defined as the maximum value of the power spectrum curve obtained from FFT analysis, representing the highest spectral power detected within the selected frequency range. Gastrointestinal myoelectrical activity was quantified based on these PSmax values. Statistical analysis Due to the small sample size (n = 4), formal tests of normality have inherently low statistical power and limited ability to reliably detect deviations from normality. Accordingly, normality assessment was not based solely on hypothesis testing; the results of the Shapiro–Wilk test were interpreted in conjunction with graphical diagnostics, including Q–Q plots and boxplots, to evaluate distributional assumptions more comprehensively. Treatment effects and temporal dynamics were evaluated using linear mixed-effects models (LMMs) fitted with the lme4 and lmerTest packages in R (version 4.5.2). The model structure was specified as: where pig was included as a random intercept to account for repeated measurements within individuals. Fixed effects were tested using Type III analysis of variance with Satterthwaite’s approximation for degrees of freedom. Post hoc pairwise comparisons were conducted using the emmeans package with Tukey’s adjustment for multiple testing. Results are presented as mean ± standard error of the mean (SEM), and a significance level of P < 0.05 was applied throughout. The R scripts used for statistical analyses are publicly available at https://doi.org/10.5281/zenodo.21720478. Results & discussion Serum cortisol levels during the experimental days The linear mixed-effects model revealed significant main effects of Treatment (control vs. stress; P < 0.0001), Time (P < 0.0001), and a significant Treatment × Time interaction (P < 0.0001). Post hoc Tukey-adjusted pairwise comparisons at each sampling time showed that cortisol levels were significantly higher under the stress condition compared to control specifically at 15–75 minutes post ACTH injection (all P < 0.001). At the remaining time points (0–15 min and 90–480 min), the differences were not statistically significant (all P > 0.05) (Fig 5.). Blood serum cortisol concentrations (mean ± SEM) on control and ACTH-injected days. During the control day, cortisol concentrations remained relatively stable, staying within the normal physiological range [9]. On the stress day, a sharp increase in cortisol was observed following ACTH injection, with peak concentrations occurring during the mid-phase (15–75 min) and gradually declining toward baseline thereafter. This pattern aligns with the expected pharmacodynamic response for Synacthen® (Novartis), confirming the effectiveness of the stimulation protocol. Similar kinetics have been documented in porcine models, where synthetic ACTH administration (10 μg/kg) elicited peak plasma cortisol within 60–70 minutes and returned to baseline within 180–240 minutes [10]. The minimal variation in cortisol on the control day suggests that the animals tolerated the procedures well, likely due to the preceding habituation period. In contrast, the relatively large standard errors on the stress day indicate substantial inter-individual variability in cortisol responses, consistent with previous reports in pigs [11,12] and humans under standardized stress protocols [13,14]. These findings support the robustness of the ACTH-induced stress model while highlighting individual differences in stress sensitivity. Gastric smooth muscle activity The linear mixed-effects model revealed no significant main effect of Treatment (control vs. stress; P = 0.314), Time (P = 0.36), and Time × Treatment interaction (P = 0.85). This indicates that gastric smooth muscle activity was not interfeared by the induced stress either during the cortisol peak or thereafter (Fig 6.). Gastric PSmax values (mean ± SEM) on control and ACTH-injected days, 0-150 minutes after ACTH injection. Although the applied ACTH-induced stress protocol successfully elevated serum cortisol levels, no statistically significant changes in gastric smooth muscle activity were observed. Visually and numerically, a modest reduction in gastric activity was apparent under the stress condition, but this decrease did not reach statistical significance. This finding is consistent with previous reports indicating that stress-induced gastrointestinal motility changes are highly context-dependent, influenced by the type, intensity, and duration of the stressor, as well as the species and experimental conditions [6,15,16]. In particular, mild, short-term endocrine stressors may not be sufficient to induce immediate or pronounced changes in gastric motility. Under the present experimental conditions, the data suggest that gastric smooth muscle activity exhibits relative resistance to mild ACTH-induced stress. To assess the potential residual effects of ACTH-induced stress on feeding-associated motility responses, animals were fed 4 hours after ACTH administration, and smooth muscle activity was recorded from 30 minutes before to 90 minutes after feeding. The linear mixed-effects model revealed no significant main effect of Treatment (control vs. stress; P = 0.222) on gastric smooth muscle activity during the afternoon feeding period. No significant main effect of Time was detected (P = 0.455), and no significant Treatment × Time interaction was observed (P = 0.625) across the 30-minute pre-feeding interval and the 90-minute post-feeding period (Fig 7.). Gastric PSmax values (mean ± SEM) on control and ACTH-injected days, 30 minutes before and 90 minutes after feeding. Nevertheless, on the control day, animals exhibited the expected postprandial increase in gastric motility, whereas this physiological rise appeared attenuated in the stress condition. Although no statistically significant Treatment, Time, or Treatment × Time effects were detected, the observed descriptive pattern may justify further investigation in larger cohorts. It is well established that stress can disrupt gastrointestinal motility through activation of specific brain nuclei and neuronal pathways, accompanied by the release of central and peripheral neurotransmitters. Substantial neuroanatomical and functional evidence from animal studies indicates that corticotropin-releasing factor plays a central role in mediating stress-induced alterations of gut motor function [6]. Although Williams et al. [17] did not observe delayed gastric transit following mild stress induction [17], the absence of a significant effect in the present study likely reflects the mild intensity and short duration of the ACTH-induced stress, as well as the animals’ prior habituation to human presence, handling, and experimental procedures, which can attenuate stress effects at the level of visceral smooth muscle [18]. Small intestinal smooth muscle activity The linear mixed-effects model demonstrated a significant main effect of Treatment (control vs. stress; P = 0.0016), while no significant main effect of Time (P = 0.589), and a significant Treatment × Time interaction (P = 0.042) on small intestinal smooth muscle activity. Post hoc Tukey-adjusted pairwise comparisons revealed that small intestinal activity was significantly lower under the stress condition during the later measured intervals. Specifically, significant differences between control and stress days were observed at 60–90 minutes (P = 0.036), 90–120 minutes (P = 0.002), and 120–150 minutes (P = 0.007), whereas no differences were detected during the earlier periods (0–30 and 30–60 minutes) (Fig 8.). Small intestinal PSmax values (mean ± SEM) on control and ACTH-injected days, 0-150 minutes after ACTH injection. The delayed onset of the motility reduction corresponds well with the known physiological kinetics of ACTH-driven cortisol elevation, which typically exerts its gastrointestinal effects with some latency [10]. Previous rat studies have demonstrated that acute stress selectively suppresses small intestinal motility while leaving gastric emptying largely unaffected, indicating region-specific sensitivity of the gut to stress exposure [17]. These stress-induced alterations are mediated via centrally acting corticotropin-releasing factor-dependent neuroendocrine pathways [19]. Together, these findings support the interpretation that the reduction in small intestinal smooth muscle activity observed between 90 and 150 minutes after ACTH administration reflects downstream neuroendocrine processes rather than an immediate stress response. Thus, the current results suggest that small intestinal smooth muscle activity may serve as a more sensitive physiological marker of mild stress compared to gastric activity. During the feeding-related observation period, in which feeding (minute 0) occurred four hours after ACTH injection, the linear mixed-effects model revealed no significant main effects of Treatment (control vs. stress; P = 0.293), Time (P = 0.179), and Treatment × Time interaction (P = 0.987) on small intestine smooth muscle activity. Mean values showed numerically lower activity values under the stress condition at all sampling intervals; however, none of these differences reached statistical significance (Fig 9.). Small intestinal PSmax values (mean ± SEM) on control and ACTH-injected days, 30 minutes before and 90 minutes after feeding. The hypothalamic-pituitary-adrenal (HPA) axis response to acute stimulation follows a well-defined temporal sequence. While ACTH is released rapidly in response to a stressor, the subsequent rise in circulating glucocorticoids, such as cortisol, is delayed due to the time required for adrenal synthesis and secretion. In pigs, plasma cortisol concentrations have been shown to peak approximately one hour after ACTH administration, followed by a gradual decline toward baseline levels within 2–3 hours under non-chronic conditions [10]. Consistent with this, rodent models of HPA axis dynamics demonstrate that cortisol responses to acute stress typically develop over tens of minutes and resolve over a similar 2–3-hour time frame, depending on stressor intensity and the efficiency of negative feedback regulation [20–22].The interpretation of these findings should also consider the frequency ranges applied for signal analysis. Gastrointestinal myoelectrical activity can be expressed either in hertz (Hz) or in CPM, the latter being the convention most commonly used in gastrointestinal myoelectrical studies and therefore applied in the present study. As comparable porcine reference data remain limited, previously published rat-derived frequency ranges were considered as a reference point [8]. However, considering available porcine studies and species-specific differences in gastrointestinal myoelectrical activity, the small intestinal frequency window was defined as 10–20 CPM [4,23,24], rather than the 20–25 CPM range reported in rats [8]. The gastric (3–5 CPM) and large intestinal (1–3 CPM) frequency windows corresponded to the ranges described in the original classification [8]. Large intestinal smooth muscle activity The linear mixed-effects model revealed a trend-level main effect of Treatment (control vs. stress; P = 0.065) on large intestinal smooth muscle activity, indicating overall lower activity under the stress condition compared with the control condition. No significant main effect of Time was detected (P = 0.722), and no significant Treatment × Time interaction was observed (P = 0.754) (Fig 10.). Large intestinal PSmax values (mean ± SEM) on control and ACTH-injected days, 0-150 minutes after ACTH injection. Stress-induced alterations in gastrointestinal motility, including reduced small intestinal transit and increased colonic activity, have been shown to be mediated by endogenous corticotropin-releasing factor (CRF) in rats [19]. Psychological stress has been shown to selectively modulate colonic motility in humans, with patients with irritable bowel syndrome exhibiting significant increases during stress exposure and subsequent decreases afterward, whereas healthy controls showed no significant changes [25]. In contrast, the current study in pigs did not confirm a statistically significant increase in large intestinal smooth muscle activity under the applied mild ACTH-induced stress protocol. This discrepancy may be partly explained by the fact that, in pigs, the characteristic CPM for each gastrointestinal segment have not been precisely established, which limits the ability to filter and interpret SMEMG signals accurately; in our analysis, we relied on reference CPM values obtained from rat models [8], whose applicability and physiological relevance in pigs have been experimentally validated [3]. During the feeding period, with feeding (minute 0) occurring four hours after ACTH injection, large intestinal smooth muscle activity tended to be lower on the stress-induced day compared with control during the feeding period (P = 0.062). Motility did not significantly vary across time points (P = 0.199), and no Treatment × Time interaction was observed (P = 0.927), indicating that the temporal motility pattern was similar in both groups. Despite the lack of significant effects, mean values showed reduced contractile activity on the stress day in the feeding-associated time window, indicating a consistent downward shift in contractile activity (Fig 11.). Large intestinal PSmax values (mean ± SEM) on control and ACTH-injected days, 30 minutes before and 90 minutes after feeding. Although large intestinal smooth muscle activity did not differ significantly between control and stress conditions during the feeding period, estimated marginal means consistently indicated lower activity under stress across all feeding-related time points. This trend suggests a subtle stress-related modulation of colonic motility that not reached statistical significance due to the mild nature of the ACTH-induced stress and the limited sample size. In contrast to several studies reporting stress-induced increases in colonic motility-primarily in rodent models or in human patients exposed to psychological or restraint stress [19,25] the present findings indicate a tendency toward reduced colonic activity in habituated pigs under endocrine-driven stress conditions. In pigs, segmental colonic motility is influenced by complex neuroendocrine and enteric regulatory mechanisms, which may result in more subtle and variable responses to mild endocrine stressors. Previous porcine in vivo studies have demonstrated that gastrointestinal myoelectrical activity can be assessed using CPM-based approaches, yielding physiologically coherent segmental patterns [3,4]. However, it should be noted that CPM reference ranges are not strictly interchangeable across species and gastrointestinal segments. In the present study, rat-derived reference values applied for gastric and small intestinal activity were consistent with previously reported physiological frequency bands, whereas notable differences were observed in colonic CPM ranges. Specifically, rodent-derived values (1–3 CPM), obtained under ex vivo organ preparation conditions [8], differ from in vivo porcine measurements reported by Salimi-Jazi et al. [4], where colonic activity is typically centered around 5–6 CPM, reflecting intact neuroenteric regulation. Importantly, this discrepancy appears to be largely confined to the large intestine, while gastric and small intestinal CPM ranges remain broadly comparable across species and experimental conditions. In this context, the observed tendency toward reduced large intestinal activity under stress may represent a mild modulatory effect of ACTH-induced endocrine activation, which did not reach statistical significance. Taken together, these findings suggest that while porcine colonic myoelectrical activity exhibits a trend toward reduced activity under acute ACTH-induced stress, the use of rat-derived CPM reference thresholds obtained under ex vivo conditions may have selectively affected colonic sensitivity in cross-species comparison, potentially contributing to the absence of statistically significant differences between experimental conditions. Conclusions The present findings indicate that SMEMG may serve as a promising non-invasive method for detecting stress-induced alterations in gastrointestinal motility in pigs. Statistically significant reductions were observed in small intestinal smooth muscle activity. Large intestinal measurements showed a consistent trend toward decreased activity under stress. Collectively, the pattern suggests that SMEMG is sufficiently sensitive to detect stress-related reductions across multiple segments of the digestive tract and may hold future potential as a tool for stress monitoring. Validation in larger cohorts and under diverse stress paradigms will be essential to determine the robustness and generalizability of this approach. 30 Jun 2026 Dear Dr. Orsolya Csötönyi, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Jul 30 2026 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. A letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'. A letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'. A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'. A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'. An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'. An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'. If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. As the corresponding author, your ORCID iD is verified in the submission system and will appear in the published article. PLOS supports the use of ORCID, and we encourage all coauthors to register for an ORCID iD and use it as well. Please encourage your coauthors to verify their ORCID iD within the submission system before final acceptance, as unverified ORCID iDs will not appear in the published article. Only the individual author can complete the verification step; PLOS staff cannot verify ORCID iDs on behalf of authors. We look forward to receiving your revised manuscript. Kind regards, Ewa Tomaszewska, DVM Ph.D Academic Editor PLOS One Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf. 2. To comply with PLOS One submissions requirements, in your Methods section, please provide additional information regarding the experiments involving animals and ensure you have included details on (1) methods of sacrifice, (2) methods of anesthesia and/or analgesia, and (3) efforts to alleviate suffering. 3. Please note that PLOS One has specific guidelines on code sharing for submissions in which author-generated code underpins the findings in the manuscript. In these cases, we expect all author-generated code to be made available without restrictions upon publication of the work. Please review our guidelines at https://journals.plos.org/plosone/s/materials-and-software-sharing#loc-sharing-code and ensure that your code is shared in a way that follows best practice and facilitates reproducibility and reuse. 4. Thank you for stating in your Funding Statement: “The study is part of PIGWEB project that has received funding from European Union's Horizon 2020 research and innovation program under Grant Agreement No 101004770. This work was supported by the Flagship Research Groups Programme of the Hungarian University of Agriculture and Life Science. Orsolya Csötönyi is supported by EKÖP-MATE/2024/25/D New National Excellence Program of the Ministry for Culture and Innovation from the source of the National Research, Development and Innovation Fund. Please provide an amended statement that declares *all* the funding or sources of support (whether external or internal to your organization) received during this study, as detailed online in our guide for authors at http://journals.plos.org/plosone/s/submit-now. Please also include the statement “There was no additional external funding received for this study.” in your updated Funding Statement. Please include your amended Funding Statement within your cover letter. We will change the online submission form on your behalf. 5. Thank you for stating the following financial disclosure: “The study is part of PIGWEB project that has received funding from European Union's Horizon 2020 research and innovation program under Grant Agreement No 101004770. This work was supported by the Flagship Research Groups Programme of the Hungarian University of Agriculture and Life Science. Orsolya Csötönyi is supported by EKÖP-MATE/2024/25/D New National Excellence Program of the Ministry for Culture and Innovation from the source of the National Research, Development and Innovation Fund. “ Please state what role the funders took in the study. If the funders had no role, please state: "The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript." If this statement is not correct you must amend it as needed. Please include this amended Role of Funder statement in your cover letter; we will change the online submission form on your behalf. 6. Please include a separate caption for each figure in your manuscript. 7. If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise. 8. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? Reviewer #1: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #1: I Don't Know ********** 3. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy Reviewer #1: No ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #1: Yes ********** Reviewer #1: This manuscript presents original research on recording electrical activity of the smooth muscles of the gastrointestinal tract using non-invasive method. Databases contain few studies on this topic. The presented research is interesting but requires confirmation using a larger number of animals in the future. The development of research using sEMG will enable the study of the influence of various factors on gastrointestinal motility. The manuscript should be supplemented with some information: In chapter ‘’Surface electromyographic measuremnets and data analysis’’: 1. What electrodes were used, and how were they attached to the skin? 2. It should be clarified whether the electrical signals were amplified using an amplifier and whether filters were used to reduce artifacts? 3. Please explain what is CMP in the text of chapter (L148-151). This information is in ‘’Intoduction’’ (L 72), but in the description of the methods this information should also be included. 4. Please explain what is PsDmax in this place (or explain in the description of each figure). This parameter is then indicated in the figures. The Authors assumed CPM of 3-5, 10-20, and 1-3 for the stomach, small intestine, and large intestine, respectively, referring to the research of Szűcs et al. (L151). In the above-mentioned work, the myoelectric cycle frequency of the ileum was 20-25. Please clarify. In chapter ‘’Results&Dissucion” the Authors could present the record primary myoelectric signal of the GIT. The record of specific spectra from FFT analysis for the stomach, small, and large intestines must be presented. The CPM assumptions for individual segments of GIT will then be confirmed. ********** what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #1: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] To ensure your figures meet our technical requirements, please review our figure guidelines: https://journals.plos.org/plosone/s/figures You may also use PLOS’s free figure tool, NAAS, to help you prepare publication quality figures: https://journals.plos.org/plosone/s/figures#loc-tools-for-figure-preparation. NAAS will assess whether your figures meet our technical requirements by comparing each figure against our figure specifications. 12 Aug 2026 Thank you for the opportunity to revise our manuscript. We have carefully addressed all comments and suggestions provided by the Academic Editor and Reviewer #1. Detailed point-by-point responses to all comments are provided in the uploaded “Response to Reviewers” document, together with the corresponding changes made to the manuscript. Submitted filename: Response to Reviewers.pdf 2 Sep 2026 Surface Electromyography as a Non-Invasive Method for Detecting Stress-Induced Changes in Gastrointestinal Motility in Pigs PONE-D-26-21675R1 Dear Dr. Orsolya Csötönyi, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. For questions related to billing, please contact billing support. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Ewa Tomaszewska, DVM Ph.D Academic Editor PLOS One Additional Editor Comments (optional): Reviewers' comments: Reviewer's Responses to Questions Comments to the Author Reviewer #1: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions??> Reviewer #1: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #1: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy Reviewer #1: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #1: Yes ********** Reviewer #1: (No Response) ********** what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #1: No ********** PONE-D-26-21675R1 PLOS One Dear Dr. Csötönyi, I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS One. Congratulations! Your manuscript is now being handed over to our production team. At this stage, our production department will prepare your paper for publication. This includes ensuring the following: * All references, tables, and figures are properly cited * All relevant supporting information is included in the manuscript submission, * There are no issues that prevent the paper from being properly typeset You will receive further instructions from the production team, including instructions on how to review your proof when it is ready. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few days to review your paper and let you know the next and final steps. Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. You will receive an invoice from PLOS for your publication fee after your manuscript has reached the completed accept phase. If you receive an email requesting payment before acceptance or for any other service, this may be a phishing scheme. Learn how to identify phishing emails and protect your accounts at https://explore.plos.org/phishing. If we can help with anything else, please email us at customercare@plos.org. Thank you for submitting your work to PLOS One and supporting open access. Kind regards, PLOS One Editorial Office Staff on behalf of Professor Ewa Tomaszewska Academic Editor PLOS One